BioSpace News Archive

Business

Sylvester Comprehensive Cancer Center at University of Miami Joins Precision Oncology Alliance Led by Caris Life Sciences

Partnership advances patient access to precision cancer care through leading scientific innovation in molecular research

March 26, 2019
·
4 min read
Pharm Country

BD Launches New Automated Flow Cytometry Sample Preparation Instrument with CE-IVD Certification

BD FACSDuet™ system raises the bar on flow cytometry automation offering a fully integrated sample-to-answer solution with the BD FACSLyric™ clinical flow cytometer

March 26, 2019
·
3 min read
Policy

NanoViricides has Requested a Pre-IND Meeting with the US FDA

NanoViricides, Inc. a company with novel platform technology to treat difficult and life-threatening viral diseases, announces that it has requested a pre-IND meeting with the US FDA, as it progresses its lead drug candidate towards human clinical trials.

March 26, 2019
·
9 min read
Deals

Realm Therapeutics Announces Cancellation of AIM Listing

Realm Therapeutics plc announced on March 15, 2019 that the listing of the Company’s Ordinary Shares on AIM will cease and cancellation will be effective from 7:00 a.m. on March 27, 2019.

March 26, 2019
·
2 min read
Business

Ichor Medical Systems Announces Collaboration and Research License Agreement with AstraZeneca to Develop DNA-based Monoclonal Antibody Platform

Ichor® Medical Systems, Inc. announced that it has entered into a collaboration and research license agreement with AstraZeneca for the development and clinical assessment of plasmid DNA constructs.

March 26, 2019
·
2 min read
ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019

Company to showcase innovative programs addressing urgent need for disease-modifying therapies selectively targeting toxic oligomers in Alzheimer’s and Parkinson’s diseases and ALS

March 26, 2019
·
2 min read
Business

Patients with hemophilia A benefit from preventive use of newer FDA-approved extended half-life therapies

Study compared therapies in areas of efficacy, safety, cost and use

March 26, 2019
·
4 min read
CannaTech Tel Aviv 2019 Schedule April 1-2

Showcasing Biggest Industry Leaders in Business, Medical Science & Technology in Tel Aviv, the World Capital of Medical Cannabis Innovation

March 26, 2019
·
5 min read
FDA

Promedior Received Breakthrough Therapy Designation from FDA for PRM-151 in Idiopathic Pulmonary Fibrosis

Promedior, Inc. announced that PRM-151, a novel investigational anti-fibrotic immunomodulator, has been granted Breakthrough Therapy designation by the U.S. Food and Drug Administration for Idiopathic Pulmonary Fibrosis.

March 26, 2019
·
6 min read
Pharm Country

Quest Diagnostics to Present New Insights from Genetic Testing at the 2019 Annual American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting

Eight presentations highlight Quest’s Advanced Diagnostics testing and research insights into hereditary genetics

March 26, 2019
·
4 min read